Neurocrine Biosciences reported $100K in Ordinary Share Capital for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Acadia Pharmaceuticals ACAD:US $ 0.02M 0M
Adamas Pharmaceuticals ADMS:US 50K 0
Agios Pharmaceuticals AGIO:US $ 0.07M 0M
Alexion Pharmaceuticals ALXN:US $ 0M 0M
ALKERMES ALKS:US $ 1.65M 0.01M
Alnylam Pharmaceuticals ALNY:US $ 1.19M 0.01M
Amgen AMGN:US $ 31877M 71M
Aptinyx Inc APTX:US $ 677K 8K
Biogen BIIB:US $ 0.1M 0M
Biomarin Pharmaceutical BMRN:US $ 0.18M 0M
Cytokinetics CYTK:US $ 0.07M 0M
Dynavax Technologies DVAX:US $ 0.11M 0M
Exelixis EXEL:US $ 0.32M 0M
Gw Pharmaceuticals GWPH:US $ 0.58M 0.01M
Halozyme Therapeutics HALO:US $ 0.14M 0M
Intercept Pharmaceuticals ICPT:US $ 0.03M 0M
Intra Cellular Therapies ITCI:US $ 0.01M 0M
IONIS PHARMACEUT IONS:US $ 0.14M 0M
Nektar Therapeutics NKTR:US $ 0.02M 0M
Neurocrine Biosciences NBIX:US $ 0.1M 0M
Prothena PRTA:US $ 0.45M 0.01M
Regeneron Pharmaceuticals REGN:US $ 0.1M 0M
Rigel Pharmaceuticals RIGL:US $ 0.17M 0M
Sarepta Therapeutics SRPT:US $ 0.01M 0M
Teva Pharmaceutical TEVA:IT 57M 0
Ultragenyx Pharmaceutical RARE:US $ 0.07M 0M
Vertex Pharmaceuticals VRTX:US $ 2.59M 0M
Xoma XOMA:US $ 85K 1000
YTE INCY:US $ 0.22M 0M
Zogenix ZGNX:US $ 0M 0M